The annual meeting of the American Academy of Dermatology is to be held in March in Denver, Colorado.
The popularity of the topic of rosacea seems to have waxed and waned over the years. This year there are mentions in keynote and symposium sessions for rosacea. It doesn’t seem like rosacea will have much of a profile this year.
Following are the rosacea topics listed to run in Denver.
AAD 2014 Forums
F038 Facing Facial Dermatoses
Director: Frank C. Powell, MD
Learning Objectives
Following this session, the attendee should be able to:
- Diagnose the different dermatoses that present in the Face.
- Formulate a treatment strategy for treatment of facial dermatoses including subtypes of Rosacea.
- Discuss etiologic factors related to the development of Rosacea and the role of Demodex mites.
Dr. Powell is well known as a rosacea researcher – having written the book Rosacea: Diagnosis and Management. This session looks similar to the one he presented in 2012 – Frank C. Powell at 2012 AAD San Diego. Dr. Powell is known for his research into demodex mites, see: Demodex Mite Bacteria Causes the Inflammation ?
AAD 2014 Symposiums
S059 Acne and Rosacea
Director: Linda F. Stein, MD
Learning Objectives
Following this session, the attendee should be able to:
- Compare insights into the pathophysiology of acne and rosacea.
- Analyze current treatment options for acne and rosacea.
- Evaluate emerging therapies for rosacea.
Dr. Stein Gold is involved with the AARS – see AARS publish their Rosacea Treatment Guidelines.
The AARS published their recommendations for treating rosacea “Consensus Recommendations From the American Acne & Rosacea Society on the Management of Rosacea, Part 1: A Status Report on the Disease State, General Measures, and Adjunctive Skin Care” – [see PDF]
AAD 2014 Courses
C008 Dermatology Review
3:50 – 4:10PM What’s New in Rosacea, Dr. Webster
Dr. Guy F Webster is known of late from his involvement in the development of the new brimonidine and oxymetazoline based treatments – see Sansrosa and Afrin Updates from Dr. Fowler & Dr. Webster
I really would like to see the dermatologists exert their collective influence to have insurance companies pay out on some IPL or Yag laser treatments as these are not always performed for cosmetic reasons. In my own instance I experience a neurogenic burn that has not been alleviated by antibiotics, oral or topical. This burning not cosmetic redness is my main issue. It is my understanding that these treatments IPL and laser are not without risk and I doubt people would engage their use cavalierly. It all begs the question “Why are laser and IPL treatments so pricey?” Will they come down in price? These issues I would like to see discussed to get us put of the Middle Ages.
To get us out of the Middle Ages